Stephen Maxted Ansell, MD, PhD

  • 23318 Citations
  • 81 Scopus h-Index
1989 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2020

Checkpoint inhibition therapy as possible frontline therapy for Hodgkin lymphoma

Khurana, A., Armand, P. & Ansell, S. M., Apr 15 2020, In : Leukemia and Lymphoma. 61, 5, p. 1063-1074 12 p.

Research output: Contribution to journalReview article

1 Scopus citations

Immunotherapy in Hodgkin and non-Hodgkin lymphoma: Innate, adaptive and targeted immunological strategies

Tun, A. M. & Ansell, S. M., Aug 2020, In : Cancer Treatment Reviews. 88, 102042.

Research output: Contribution to journalReview article

2019

Immunotherapy in Hodgkin Lymphoma: The Road Ahead

Ansell, S. M., May 2019, In : Trends in Immunology. 40, 5, p. 380-386 7 p.

Research output: Contribution to journalReview article

2 Scopus citations

The potential role of glycogen metabolism in diffuse large B-cell lymphoma

Jalali, S. & Ansell, S. M., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalReview article

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis

Wang, Y., Zhou, S., Yang, F., Qi, X., Wang, X., Guan, X., Shen, C., Duma, N., Vera Aguilera, J., Chintakuntlawar, A., Price, K. A., Molina, J. R., Pagliaro, L., Halfdanarson, T. R., Grothey, A., Markovic, S. N., Nowakowski, G. S., Ansell, S. M. & Wang, M. L., Jul 2019, In : JAMA Oncology. 5, 7, p. 1008-1019 12 p.

Research output: Contribution to journalReview article

78 Scopus citations

Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

Jain, T., Bar, M., Kansagra, A. J., Chong, E. A., Hashmi, S. K., Neelapu, S. S., Byrne, M., Jacoby, E., Lazaryan, A., Jacobson, C. A., Ansell, S. M., Awan, F. T., Burns, L., Bachanova, V., Bollard, C. M., Carpenter, P. A., DiPersio, J. F., Hamadani, M., Heslop, H. E., Hill, J. A. & 13 others, Komanduri, K. V., Kovitz, C. A., Lazarus, H. M., Serrette, J. M., Mohty, M., Miklos, D., Nagler, A., Pavletic, S. Z., Savani, B. N., Schuster, S. J., Kharfan-Dabaja, M. A., Perales, M. A. & Lin, Y., 2019, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalReview article

14 Scopus citations
2018

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma

Wang, Y., Nowakowski, G. S., Wang, M. L. & Ansell, S. M., Apr 23 2018, In : Journal of Hematology and Oncology. 11, 1, 57.

Research output: Contribution to journalReview article

4 Scopus citations

Immunotherapy of Hodgkin Lymphoma: Mobilizing the Patient's Immune Response

Ansell, S. M., Sep 1 2018, In : Cancer Journal (United States). 24, 5, p. 249-253 5 p.

Research output: Contribution to journalReview article

1 Scopus citations

T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines

Horwitz, S. M., Ansell, S. M., Ai, W. Z., Barnes, J., Barta, S. K., Choi, M., Clemens, M. W., Dogan, A. M., Greer, J. P., Halwani, A., Bradley, M. H., Hoppe, R. T., Jacobsen, E., Jagadeesh, D., Kim, Y. H., Lunning, M. A., Mehta, A., Mehta-Shah, N., Oki, Y., Olsen, E. A. & 11 others, Pro, B., Rajguru, S. A., Shanbhag, S., Shustov, A., Sokol, L., Torka, P., Wilcox, R., William, B., Zain, J., Dwyer, M. A. & Sundar, H., Feb 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 2, p. 123-135 13 p.

Research output: Contribution to journalReview article

16 Scopus citations
2017

Advances in the understanding of IgM monoclonal gammopathy of undetermined significance

Paludo, J. & Ansell, S. M., 2017, In : F1000Research. 6, 2142.

Research output: Contribution to journalReview article

2 Scopus citations

Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy

Gopal, A. K., Kahl, B. S., Flowers, C. R., Martin, P., Ansell, S. M., Abella-Dominicis, E., Koh, B., Ye, W., Barr, P. M., Salles, G. A. & Friedberg, J. W., Jun 1 2017, In : Blood. 129, 22, p. 3037-3039 3 p.

Research output: Contribution to journalReview article

43 Scopus citations

Recommendations for clinical trial development in follicular lymphoma

Maddocks, K., Barr, P. M., Cheson, B. D., Little, R. F., Baizer, L., Kahl, B. S., Leonard, J. P., Fowler, N., Gordon, L. I., Link, B. K., Friedberg, J. W. & Ansell, S. M., 2017, In : Journal of the National Cancer Institute. 109, 3, djw255.

Research output: Contribution to journalReview article

15 Scopus citations
2016

Bone marrow microenvironment in Waldenstrom's Macroglobulinemia

Jalali, S. & Ansell, S. M., Jun 1 2016, In : Best Practice and Research: Clinical Haematology. 29, 2, p. 148-155 8 p.

Research output: Contribution to journalReview article

4 Scopus citations
14 Scopus citations

Immune checkpoint blockade in lymphoid malignancies

Thanarajasingam, G., Thanarajasingam, U. & Ansell, S. M., Jun 1 2016, In : The FEBS journal. 283, 12, p. 2233-2244 12 p.

Research output: Contribution to journalReview article

10 Scopus citations

Novel agents in the treatment of Hodgkin lymphoma: Biological basis and clinical results

Younes, A. & Ansell, S. M., Jul 1 2016, In : Seminars in Hematology. 53, 3, p. 186-189 4 p.

Research output: Contribution to journalReview article

23 Scopus citations

Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia

Kyle, R. A., Ansell, S. M. & Kapoor, P., Jun 1 2016, In : Best Practice and Research: Clinical Haematology. 29, 2, p. 179-186 8 p.

Research output: Contribution to journalReview article

1 Scopus citations

Recent advances in the management of Hodgkin lymphoma

Villasboas, J. C. & Ansell, S. M., 2016, In : F1000Research. 5, 768.

Research output: Contribution to journalReview article

4 Scopus citations

Role of the tumor microenvironment in mature B-cell lymphoid malignancies

Fowler, N. H., Cheah, C. Y., Gascoyne, R. D., Gribben, J., Neelapu, S. S., Ghia, P., Bollard, C., Ansell, S., Curran, M., Wilson, W. H., O’Brien, S., Grant, C., Little, R., Zenz, T., Nastoupil, L. J. & Dunleavy, K., Apr 30 2016, In : Haematologica. 101, 5, p. 531-540 10 p.

Research output: Contribution to journalReview article

28 Scopus citations

Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia

Leblond, V., Kastritis, E., Advani, R., Ansell, S. M., Buske, C., Castillo, J. J., García-Sanz, R., Gertz, M., Kimby, E., Kyriakou, C., Merlini, G., Minnema, M. C., Morel, P., Morra, E., Rummel, M., Wechalekar, A., Patterson, C. J., Treon, S. P. & Dimopoulos, M. A., Sep 8 2016, In : Blood. 128, 10, p. 1321-1328 8 p.

Research output: Contribution to journalReview article

95 Scopus citations
2014

Brentuximab vedotin

Ansell, S. M., Nov 20 2014, In : Blood. 124, 22, p. 3197-3200 4 p.

Research output: Contribution to journalReview article

53 Scopus citations
3 Scopus citations
2013
52 Scopus citations

WaldenstroM Macroglobulinaemia: The Key Questions

D'Souza, A., Ansell, S., Reeder, C. & Gertz, M. A., Aug 2013, In : British journal of haematology. 162, 3, p. 295-303 9 p.

Research output: Contribution to journalReview article

5 Scopus citations
2012

Molecular pathogenesis of Waldenström's macroglobulinemia

Braggio, E., Philipsborn, C., Novak, A., Hodge, L., Ansell, S. & Fonseca, R., Sep 1 2012, In : Haematologica. 97, 9, p. 1281-1290 10 p.

Research output: Contribution to journalReview article

18 Scopus citations

Stem cell transplant for Waldenström macroglobulinemia: An underutilized technique

Gertz, M. A., Reeder, C. B., Kyle, R. A. & Ansell, S. M., Sep 1 2012, In : Bone Marrow Transplantation. 47, 9, p. 1147-1153 7 p.

Research output: Contribution to journalReview article

28 Scopus citations

The B7 Homologues and their Receptors in Hematologic Malignancies

Wilcox, R. A., Ansell, S. M., Lim, M. S., Zou, W. & Chen, L., Jun 1 2012, In : European Journal of Haematology. 88, 6, p. 465-475 11 p.

Research output: Contribution to journalReview article

14 Scopus citations
2011

Innate immune B cells gone bad

Ansell, S. M., Nov 7 2011, In : Oncology. 25, 12

Research output: Contribution to journalReview article

Novel therapeutic agents for B-cell lymphoma: Developing rational combinations

Reeder, C. B. & Ansell, S. M., Feb 3 2011, In : Blood. 117, 5, p. 1453-1462 10 p.

Research output: Contribution to journalReview article

38 Scopus citations
2010

Diagnosis and management of waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

Ansell, S. M., Kyle, R. A., Reeder, C. B., Fonseca, R., Mikhael, J. R., Morice, W. G., Bergsagel, P. L., Buadi, F. K., Colgan, J. P., Dingli, D., Dispenzieri, A., Greipp, P. R., Habermann, T. M., Hayman, S. R., Inwards, D. J., Johnston, P. B., Kumar, S. K., Lacy, M. Q., Lust, J. A., Markovic, S. N. & 13 others, Micallef, I. N. M., Nowakowski, G. S., Porrata, L. F., Roy, V., Russell, S. J., Detweiler Short, K. E., Stewart, A. K., Thompson, C. A., Witzig, T. E., Zeldenrust, S. R., Dalton, R. J., Rajkumar, S. V. & Gertz, M. A., Sep 2010, In : Mayo Clinic proceedings. 85, 9, p. 824-833 10 p.

Research output: Contribution to journalReview article

106 Scopus citations
2009

The role of Treg cells in the cancer immunological response

Yang, Z. Z. & Ansell, S. M., Sep 18 2009, In : American Journal of Immunology. 5, 1, p. 17-28 12 p.

Research output: Contribution to journalReview article

15 Scopus citations
2006

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia

Elliott, M. A., Tefferi, A., Hogan, W. J., Letendre, L., Gastineau, D. A., Ansell, S. M., Dispenzieri, A., Gertz, M. A., Hayman, S. R., Inwards, D. J., Lacy, M. Q., Micallef, I. N., Porrata, L. F. & Litzow, M. R., Jun 1 2006, In : Bone Marrow Transplantation. 37, 11, p. 1003-1008 6 p.

Research output: Contribution to journalReview article

44 Scopus citations

An APRIL to remember: Novel TNF ligands as therapeutic targets

Dillon, S. R., Gross, J. A., Ansell, S. M. & Novak, A. J., Mar 1 2006, In : Nature Reviews Drug Discovery. 5, 3, p. 235-246 12 p.

Research output: Contribution to journalReview article

252 Scopus citations

Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma

Buadi, F. K., Micallef, I. N., Ansell, S. M., Porrata, L. F., Dispenzieri, A., Elliot, M. A., Gastineau, D. A., Gertz, M. A., Lacy, M. Q., Litzow, M. R., Tefferi, A. & Inwards, D. J., Jun 1 2006, In : Bone Marrow Transplantation. 37, 11, p. 1017-1022 6 p.

Research output: Contribution to journalReview article

46 Scopus citations

Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies

Shivakumar, L. & Ansell, S., Sep 2006, In : Clinical Lymphoma and Myeloma. 7, 2, p. 106-108 3 p.

Research output: Contribution to journalReview article

33 Scopus citations
2004

Antibody therapy for non-Hodgkin's lymphoma

Ansell, S. M., Apr 1 2004, In : Current Opinion in Molecular Therapeutics. 6, 2, p. 175-181 7 p.

Research output: Contribution to journalReview article

1 Scopus citations

Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate

Gertz, M. A., Lacy, M. Q., Dispenzieri, A., Ansell, S. M., Elliott, M. A., Gastineau, D. A., Inwards, D. J., Micallef, I. N. M., Porrata, L. F., Tefferi, A. & Litzow, M. R., Dec 1 2004, In : Bone Marrow Transplantation. 34, 12, p. 1025-1031 7 p.

Research output: Contribution to journalReview article

95 Scopus citations
2003
10 Scopus citations
1999

Primary thyroid lymphoma

Ansell, S. M., Grant, C. S. & Habermann, T. M., Jun 22 1999, In : Seminars in oncology. 26, 3, p. 316-323 8 p.

Research output: Contribution to journalReview article

160 Scopus citations